Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROFE: Goserelin vs Oral Contraceptives for Ovarian Protection in Hodgkin Lymphoma
NCT01014507Phase 2Completed
- Sponsor
- University of Cologne
- Start
- Jan 2004
- Primary completion
- Sep 2009
- Modality
- Peptides, Small Molecules
01
Overview
A Phase 2 trial of goserelin in ovarian toxicity (ovotoxicity), sponsored by University of Cologne. Started Jan 2004; status: completed.
02
Drugs
goserelin
03
Conditions
ovarian toxicity (ovotoxicity)
Beyond the preview
Go deeper on NCT01014507.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01014507.